OSE Immunotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 16 shareholders own 39.68% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17.3%	Emile Loria	3,199,353	€12.0m	0%	no data
10.9%	Dominique Costantini	2,007,163	€7.5m	0%	no data
4.97%	Alexis Peyroles	918,499	€3.5m	0%	no data
2.29%	Maryvonne Hiance	424,084	€1.6m	0%	no data
1.1%	Sophie Brouard	202,904	€762.9k	0%	no data
1.04%	Nicolas Poirier	192,802	€724.9k	0%	no data
0.76%	Saint Olive Gestion	140,000	€526.4k	0%	0.06%
0.49%	La Française Systematic Asset Management GmbH	90,000	€338.4k	0%	0.19%
0.26%	Financiere Arbevel	48,517	€182.4k	0%	0.03%
0.17%	Gérard Tobelem	31,250	€117.5k	0%	no data
0.16%	Jean-Patrick Demonsang	30,000	€112.8k	0%	no data
0.077%	Friedland Gestion	14,325	€53.9k	0%	0.69%
0.065%	Meeschaert Asset Management	12,000	€45.1k	0%	0.01%
0.065%	AIPM Azur International Portfolio Management AG	12,000	€45.1k	0%	0.93%
0.04%	Didier Hoch	7,334	€27.6k	0%	no data
0.032%	Dimensional Fund Advisors LP	5,847	€22.0k	0%	no data